HA
RLYB icon

HHLR Advisors’s Rallybio RLYB Stock Holding History

HHLR Advisors’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-112,959
Closed -$8.62M – 77
2021
Q4 		$8.62M Hold
112,959
– – 0.13% 52
2021
Q3 		$15.9M Buy
+112,959
New +$13.2M 0.21% 51

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

HHLR Advisors's RLYB Position: Q1 2022 in Review

HHLR Advisors sold out of Rallybio (RLYB) in Q1 2022, closing a stake of 112,959 shares — an estimated $8.62M sold.

HHLR Advisors first reported a position in RLYB in Q3 2021 and held it in 2 quarters. The position peaked at $15.9M in Q3 2021. 47 funds tracked by Wall St. Rank hold RLYB as of Q1 2022.

  • HHLR Advisors reported no remaining Rallybio position as of Q1 2022 after selling out during the quarter.
  • HHLR Advisors sold 112,959 Rallybio shares in Q1 2022, an estimated $8.62M.
  • HHLR Advisors first reported a position in Rallybio in Q3 2021 and held it in 2 quarters.
  • HHLR Advisors's Rallybio position peaked at $15.9M in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Rallybio as of Q1 2022.

Based on HHLR Advisors's 13F filing for Q1 2022, filed 16 May 2022.